Indiana officials approve to suspend business with the Massachusett pharmacy that's at the center of the recent meningitis outbreak. The Indiana Board of Pharmacy voted 7-0-0 to accept the suspension agreement between the Indiana Attorney General's Office and the New England Compounding Center. This gives the Attorney General's Office time to draft a formal administrative complaint. The pharmacy has been linked to 43 cases of fungal meningitis stemming from steroid injections. More than 1,000 people in Indiana have been exposed to the injections.